SCHEMBL18905618

SCHEMBL18905618

CCOC(C(=O)c1ccc(-c2cc(OC)c(C)c(OC)c2)o1)c1ccc(N2CCOCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.55
PDE2A O00408 1/20 0.55
PDE5A O76074 1/20 0.55
HIF1A Q16665 2/20 0.46
MAPT P10636 7/20 0.42
TGFBR1 P36897 1/20 0.41
ACVR1 Q04771 1/20 0.41
MTOR P42345 2/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 3/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
LMNA P02545 2/20 0.39
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTT P42858 1/20 0.38
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12258882 0.93 PDE10A (0.53) PDE10APDE2APDE5AHIF1AMAPT
SCHEMBL2386113 0.92 PDE10A (0.63) PDE10APDE2APDE5AHIF1AMAPT
SCHEMBL2523973 0.92 PDE10A (0.63) PDE10APDE2APDE5AHIF1AMAPT
SCHEMBL2388604 0.92 PDE10A (0.52) PDE10APDE2APDE5AHIF1AMAPT
SCHEMBL12258874 0.92 PDE10A (0.52) PDE10APDE2APDE5AHIF1AMAPT
SCHEMBL18905617 0.91 HIF1A (0.48) PDE10APDE2APDE5AHIF1AMAPT
SCHEMBL18905628 0.89 PDE10A (0.44) PDE10APDE2APDE5AHIF1AMAPT
SCHEMBL2386734 0.84 MAPT (0.45) PDE10APDE2APDE5AHIF1AMAPT
SCHEMBL12258820 0.83 MAPT (0.51) PDE10APDE2APDE5AHIF1AMAPT
SCHEMBL12258862 0.83 MTOR (0.52) PDE10APDE2APDE5AHIF1AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152238-A1 PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS OMEROS CORPORATION 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152238-A1 PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS PDE10A, PDE9A, PDE7A PDE10A 1/4885PDE2A 9/4885PDE5A 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.